Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/7/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. William G. Goodman

Wrong Dr. William G. Goodman?

Medical Affairs Director

Phone: (805) ***-****  
Amgen Inc.
One Amgen Center Drive
Thousand Oaks , California 91320
United States

Company Description: Amgen Inc. (Amgen) is an independent biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for grievous illnesses. It...   more

Employment History

  • Clinical Research Medical Director
    Amgen Inc.
  • Professor of Medicine At the Division of Nephrology
  • Researcher
  • Kidney Specialist
  • Director of the Bone Histology Laboratory
    David Geffen School of Medicine at the University of California , Los Angeles
  • Professor of Medicine
    David Geffen School of Medicine at the University of California , Los Angeles
  • Professor of Medicine
    David Geffen School of Medicine at UCLA
  • Kidney Specialist
    David Geffen School of Medicine at UCLA


  • MD
  • medical degree
    The Ohio State University College of Medicine
38 Total References
Web References
BioDiscussion, 5 Oct 2014 [cached]
William Goodman, MD BioDiscussion
William Goodman, MD Professor of Medicine Director, Bone, Histology and Molecular Bone Labs of the CRC UCLA School of Medicine
William Goodman, MD has documented that he/she has nothing to disclose.
William Goodman, ..., 2 June 2014 [cached]
William Goodman, MD
William Goodman, MD Professor of Medicine, Division of Nephrology, UCLA School of Medicine, UCLA Medical Center, Los Angeles, CA.
Dr. Goodman discloses no apparent conflicts of pertaining to the material discussed in this talk.
Vital news for Kidney (renal), Heart, and Diabetes Patient, 5 Mar 2006 [cached]
William Goodman, MD, the UCLA researcher who is the lead author of the study, says that he puts his patients on a mixed regimen of Renagel and calcium in an effort to moderate calcium intake while containing costs.
Corp Watch: US: Strengthening Bones, Raising Questions, 23 April 2004 [cached]
The Amgen drug "is a new tool in the armamentarium," said Dr. William G. Goodman, a UCLA kidney specialist who tested cinacalcet in human trials."We can treat patients better than in the past."
However, Goodman said that though the Kidney Foundation's calcium targets were probably good news for Amgen, they might not be ideal for all patients.The guidelines say calcium should be at the "low end" of what is normal in healthy people a range Goodman called "too rigid."
Calcium levels vary among individuals, and the amount needed for bone renewal and repair also varies, he said.In fact, the target in Europe is 12% higher than what the foundation recommends.
"What are the long-term effects of keeping calcium lower than what is normal for these people?"Goodman, an expert on calcium in dialysis patients, asked.
Faculty, 4 Nov 2006 [cached]
William G. Goodman, MD
William G. Goodman, MD, is Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), where he is Director of the Bone Histology Laboratory at UCLA Medical Center.After earning his medical degree from The Ohio State University College of Medicine in Columbus, Dr. Goodman completed an internship and residency in internal medicine at Henry Ford Hospital in Detroit, Michigan, where he served as chief resident.Following residency, Dr. Goodman completed a fellowship in nephrology at the University of Washington in Seattle.He is board-certified in internal medicine and nephrology.Dr. Goodman's research on secondary hyperparathyroidism, renal osteodystrophy, and vascular calcification in patients on dialysis has been published in numerous peer-reviewed journals, including The New England Journal of Medicine, Kidney International, American Journal of Kidney Disease, and Pediatric Nephrology.He has contributed to more than 20 book chapters and 150 abstracts.He sits on the editorial boards of Journal of the American Society of Nephrology and Kidney International and serves as a reviewer for a number of scientific publications including The Journal of Clinical Investigation, The New England Journal of Medicine, and The Lancet, among others.
Dr. Goodman's commitment to his field extends to the community where he has served as a member of the Scientific Advisory Council of the National Kidney Foundation of Southern California and as a member of the Program Committee for the NKF spring clinical meetings.He is a 20-year member of many professional organizations, including the American Society of Nephrology, the International Society of Nephrology, and The American Society for Bone and Mineral Research.
Other People with the name "Goodman":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.